Purification and characterization of a complex from placental syncytiotrophoblast microvillous membranes which inhibits the proliferation of human umbilical vein endothelial cells
- PMID: 9950147
- DOI: 10.1053/plac.1998.0351
Purification and characterization of a complex from placental syncytiotrophoblast microvillous membranes which inhibits the proliferation of human umbilical vein endothelial cells
Abstract
The signs of pre-eclampsia are thought to arise from maternal endothelial dysfunction caused by circulating factors of placental origin. Syncytiotrophoblast microvillous membranes (STBM) cause endothelial disruption and inhibit proliferation in vitro. Significantly increased amounts of STBM can be detected in blood from pre-eclamptic women and could contribute to endothelial dysfunction in vivo. This study purified a complex from STBM which inhibits the proliferation of cultured human endothelial cells. Integral membrane proteins were solubilized with sucrose monolaurate. Anion exchange chromatography yielded two peaks of anti-proliferative activity. Only the second peak was specific to STBM and was subjected to further separation by Sephacryl S-200 gel filtration chromatography (GFC). A single peak of specific activity eluted close to the void volume, at a position unaltered by added denaturing agents, guanidium chloride or urea. On Sephacryl S-300 GFC, two peaks were obtained of 410 and 820 kDa, with similar anti-proliferative activity and protein components (by SDS-polyacrylamide gel electrophoresis). The major protein bands were as integrins alpha5 and alpha v, dipeptidyl peptidase IV, alpha-actinin, transferrin, transferrin receptor, placental alkaline phosphatase and monoamine oxidase A.
Similar articles
-
Adhesion molecules of syncytiotrophoblast microvillous membranes inhibit proliferation of human umbilical vein endothelial cells.Placenta. 2000 Mar-Apr;21(2-3):150-9. doi: 10.1053/plac.1999.0476. Placenta. 2000. PMID: 10736237
-
Effect of syncytiotrophoblast microvillous membrane treatment on gene expression in human umbilical vein endothelial cells.BJOG. 2006 Nov;113(11):1270-9. doi: 10.1111/j.1471-0528.2006.01061.x. BJOG. 2006. PMID: 17059391
-
A comparative study of the effect of three different syncytiotrophoblast micro-particles preparations on endothelial cells.Placenta. 2005 Jan;26(1):59-66. doi: 10.1016/j.placenta.2004.04.004. Placenta. 2005. PMID: 15664412
-
Endothelial progenitor cells in pregnancy.Reproduction. 2007 Jan;133(1):1-9. doi: 10.1530/REP-06-0219. Reproduction. 2007. PMID: 17244727 Review.
-
The functions of microparticles in pre-eclampsia.Semin Thromb Hemost. 2011 Mar;37(2):146-52. doi: 10.1055/s-0030-1270342. Epub 2011 Mar 2. Semin Thromb Hemost. 2011. PMID: 21370216 Review.
Cited by
-
Role of placenta in preeclampsia.Endocrine. 2002 Oct;19(1):103-11. doi: 10.1385/ENDO:19:1:103. Endocrine. 2002. PMID: 12583607 Review.
-
Protein composition of microparticles shed from human placenta during placental perfusion: Potential role in angiogenesis and fibrinolysis in preeclampsia.Placenta. 2011 Jan;32(1):63-9. doi: 10.1016/j.placenta.2010.10.011. Epub 2010 Nov 11. Placenta. 2011. PMID: 21074265 Free PMC article.
-
Circulating and Vascular Bioactive Factors during Hypertension in Pregnancy.Curr Bioact Compd. 2010 Mar 1;6(1):60-75. doi: 10.2174/157340710790711737. Curr Bioact Compd. 2010. PMID: 20419111 Free PMC article.
-
Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy.Cardiovasc Hematol Disord Drug Targets. 2010 Mar;10(1):33-52. doi: 10.2174/187152910790780096. Cardiovasc Hematol Disord Drug Targets. 2010. PMID: 20041838 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources